CNGGF
Cann Group Limited engages in the breeding, cultivation, production, manufacturing, clinical evaluation, and supplying medicinal cannabis for sale and use within Australia and for overseas export markets. It licenses to undertake research and to cultivate cannabis for human medicinal and research purposes. The company was founded in 2014 and is based in Port Melbourne, Australia.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2025 Q2 | 0.03 | $5M | -$114,953 |
| 2025 Q4 | -0.02 | $7M | -$5M |
| 2024 Q2 | -0.02 | $6M | -$5M |
| 2024 Q4 | -0.08 | $9M | -$9M |
| 2023 Q2 | -0.03 | $9M | -$8M |
| 2023 Q4 | -0.04 | $8M | -$11M |
| 2022 Q2 | -0.05 | $6M | -$15M |
| 2022 Q4 | -0.05 | $3M | -$20M |